On the other hand, demethylation and/or amplification of the 14q32 region can lead to overexpression of miR-493-3p and miR-433-3p, resulting in loss of Mad2 and insensitivity of tumor cells to taxol treatment. Here, MAD2L1 is linked to neoplasm.